...
首页> 外文期刊>Arquivo Brasileiro de Medicina Veterinaria e Zootecnia >Implant of Port-o-Cath for antineoplastic chemotherapy in a canine: case report
【24h】

Implant of Port-o-Cath for antineoplastic chemotherapy in a canine: case report

机译:在犬中植入用于抗肿瘤化疗的 Port-o-Cath:病例报告

获取原文
获取原文并翻译 | 示例
           

摘要

The Port-a-Cath is a totally implantable central venous catheter that allows the infusion of chemotherapeutic agents, blood products, parenteral nutrition, and blood sample collection. This work reports the case of a dog with a tumor in the pelvic limb that was treated surgically and received the catheter for cancer chemotherapy. The patient was diagnosed with synovial sarcoma, an uncommon tumor in dogs that usually affects the joints and requires multimodal therapy. The treatment was done in two steps, in the first the limb was amputated and in the second the Port-a-Cath implantation and the excision of the metastatic nodule were performed. The dog responded well to surgery and chemotherapy sessions held with proper functioning of the catheter, and died from other causes 90 days after the procedure. The implantation of Port-a-Cath for chemotherapy is a great ally of multimodal therapy recommended for cancer, so this catheter may be considered for patients requiring chemotherapy medication for a long period.
机译:Port-a-Cath 是一种完全植入式的中心静脉导管,可以输注化疗药物、血液制品、肠外营养和血样采集。这项工作报告了一只骨盆肢体肿瘤的狗的病例,该狗接受了手术治疗并接受了癌症化疗的导管。患者被诊断出患有滑膜肉瘤,这是一种在狗中不常见的肿瘤,通常影响关节,需要多模式治疗。治疗分两步进行,第一步截肢,第二步进行导管移植和转移性结节切除。这只狗对导管正常运作的手术和化疗反应良好,并在手术后 90 天死于其他原因。植入 Port-a-Cath 进行化疗是推荐用于癌症的多模式治疗的重要盟友,因此对于需要长期化疗药物的患者,可以考虑使用这种导管。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号